BN
BNB Plus Corp. (BNBX)
NASDAQ·Healthcare·Biotechnology
$0.52
-1.36%
Mkt Cap $989.05K
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | — | $565.39K | — | — | -$2.08 | — | — | — |
| Q4 2025 Dec 22, 2025 | $1.63M | $199.43K | -87.73% | -$22.50 | -$3.17 | +85.91% | — | — |
| Q3 2025 Aug 14, 2025 | $1.28M | $304.39K | -76.14% | -$37.50 | $34.00 | +190.67% | — | — |
| Q2 2025 May 15, 2025 | $1.19M | $983.37K | -17.01% | -$45.00 | -$15.35 | +65.89% | — | — |
| Q4 2024 Dec 31, 2024 | $1.04M | $1.20M | +15.34% | -$243.75 | -$62.81 | +74.23% | — | — |
| Q3 2024 Sep 30, 2024 | $899.00K | $813.11K | -9.55% | -$255.00 | -$239.69 | +6.00% | — | — |
| Q2 2024 Jun 30, 2024 | $1.08M | $472.79K | -56.18% | -$371.25 | $1170.48 | +415.28% | — | — |
| Q2 2024 May 10, 2024 | $951.00K | $929.63K | -2.25% | -$3375.00 | -$3982.50 | -18.00% | — | — |
| Q1 2024 Feb 8, 2024 | $776.00K | $891.16K | +14.84% | -$4650.00 | -$1350.00 | +70.97% | — | — |
| Q4 2023 Dec 7, 2023 | $1.68M | $779.74K | -53.60% | -$3975.00 | -$3900.00 | +1.89% | — | — |